Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2000
10/31/2000CA2025605C Method of purifying human serum albumin
10/31/2000CA1341130C Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
10/30/2000CA2306732A1 Enhanced growth of lactic acid bacteria in milk
10/26/2000WO2000063667A2 Methods for identifying modulators of n-type ion channel inactivation
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063435A2 Method of identifying toxic agents using differential gene expression
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063433A1 PHARMACOLOGICAL TARGETING OF mRNA CAP FORMATION
10/26/2000WO2000063424A2 Method for screening compounds using nematode worms
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063412A1 HETEROPOLYSACCHARIDE PRODUCED BY $i(PSEUDOMONAS SP)
10/26/2000WO2000063408A2 Apparatus for, and method of, introducing a substance into a cell by electroporation
10/26/2000WO2000063407A2 Apparatus for, and method of, introducing a substance into a cell by electroporation
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063391A2 Nucleic acid sequences to proteins involved in tocopherol synthesis
10/26/2000WO2000063389A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis
10/26/2000WO2000063388A1 Novel desensitized aspartokinase
10/26/2000WO2000063384A1 Streptokinase fragments and their use for inhibiting cell death
10/26/2000WO2000063382A1 Genes and expression products from hematopoietic cells
10/26/2000WO2000063380A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063377A1 Adipocyte complement related protein homolog zacrp3
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063371A1 Protease activated receptor 2 variants
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063368A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000WO2000063367A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000WO2000063360A1 Combinatorial method for producing nucleic acids
10/26/2000WO2000063354A1 Novel amidase gene
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063346A1 A bacillus protein production cell
10/26/2000WO2000063345A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063344A1 Cultivation of zygomycetes from spent sulfite liquor
10/26/2000WO2000063343A2 Bacterial culture
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063244A1 Parasite antigens
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062773A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000049134A8 Secreted proteins and polynucleotides encoding them
10/26/2000WO2000040727A3 Recombinant growth factor with the biological activity of a g-csf (granulocyte colony stimulating factor)
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000036135A3 Screening methods based on the use of protein kinases
10/26/2000WO2000036108A3 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides
10/26/2000WO2000034449A3 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000024770A9 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
10/26/2000WO2000020601A3 Polyketide synthase enzymes and recombinant dna constructs therefor
10/26/2000WO2000018906A3 Shuffling of codon altered genes
10/26/2000WO2000011172A9 Antithrombin nucleotides and proteins from horn fly
10/26/2000DE19918619A1 Process for obtaining recombinant hepatitis B surface antigen from methylotrophic yeast cells uses high-pressure homogenisation to fracture the cells
10/26/2000DE19918365A1 New nucleic acid encoding flavone synthase II, useful e.g. for producing transgenic plants with altered flower color or flavone content
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2371976A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370616A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis
10/26/2000CA2370615A1 Methods for identifying modulators of n-type ion channel inactivation
10/26/2000CA2370609A1 Adipocyte complement related protein homolog zacrp3
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370521A1 Streptokinase fragments and their use for inhibiting cell death
10/26/2000CA2370272A1 Protease activated receptor 2 variants
10/26/2000CA2370246A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000CA2370239A1 Pseudomycin production by pseudomonas syringae
10/26/2000CA2370142A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000CA2369969A1 Method of identifying toxic agents using differential gene expression
10/26/2000CA2369844A1 Nucleic acid sequences to proteins involved in tocopherol synthesis
10/26/2000CA2369734A1 Method for screening compounds using nematode worms
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2364191A1 Parasite antigens
10/26/2000CA2349827A1 Pharmacological targeting of mrna cap formation
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046624A2 Method of disposing hairs or feathers using fungi
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045920A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
10/25/2000EP1045916A1 Enzymatic conversion of gdp-mannose to gdp-fucose
10/25/2000EP1045914A1 Testis-specific human svph1-8 proteinase
10/25/2000EP1045913A2 Human protease molecules
10/25/2000EP1045912A1 Polyketides and their synthesis
10/25/2000EP1045910A1 Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
10/25/2000EP1045907A1 Dkr polypeptides
10/25/2000EP1045906A1 Apo-2 ligand
10/25/2000EP1045905A2 Il-17rh dna and polypeptides
10/25/2000EP1045902A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045857A1 MULTIPLE DRUG RESISTANCE GENE atrC OF ASPERGILLUS NIDULANS
10/25/2000EP1045647A1 System for freeze granulation
10/25/2000EP1045646A1 Method for freeze granulation